Faeth Therapeutics, Inc. Common Stock FTH
$12.68
-42.49%
at last close
Market Cap$569.86 million
P/E Ratio—
Div Yield—
Volume4.05M
52-Week Range
$10.45$42.14
Analyst Ratings
- Consensus
- Buy — 12 Buy · 0 Hold · 0 Sell (12 analysts)
- Avg. Price Target
- $57.80 (+355.8% upside)
Key Stats
- Today's Range
- $10.45 – $16.64
- 50-Day Range
- $10.45 – $42.14
- 52-Week Range
- $10.45 – $42.14
- Volume
- 4.05 million shs
- Average Volume
- 477K shs
- Market Cap
- $569.86 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.02%
- Days to Cover
- 6.95
About Faeth Therapeutics, Inc. Common Stock
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Related Stocks
Compare head-to-head: FTH vs LLY·FTH vs JNJ·FTH vs ABBV·FTH vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.